Skip to content

A Study on the Clinical Efficacy of a New Type of Medium-Frequency Electrotherapy Device for the Treatment of Neck and Low Back Pain

A Study on the Clinical Efficacy of a New Type of Medium-Frequency Electrotherapy Device for the Treatment of Neck and Low Back Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116303
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-08
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck and Low Back Pain

Interventions

Control group for neck pain:The control group was treated with a conventional modulated computerized medium-frequency electrotherapy device, with the low-frequency and medium-frequency parameters adju
Intensity: Adjusted to the patient’s tolerance
Treatment Duration: 15–20 minutes per session
Treatment Frequency: Once daily, with an interval of no more than 3 days between two treatments, for a total of 5 sessions.
Experimental group for neck pain:The experimental group was treated with the new type of medium-frequency electrotherapy device. Treatment Sites: Bilateral posterior cervical muscles, bilateral upper
Control group for low back pain:The control group was treated with a conventional modulated computerized medium-frequency electrotherapy device, with the following parameters: medium frequency ranging
low frequency ranging from 0 to 150 Hz
output current intensity ranging from 15 to 90 mA (the same parameter protocol was adopted, with no restrictions on the device brand).Treatment Sites: Bilateral lumbar and dorsal muscles
Treatment Duration: 15 minutes per session
Experimental group for low b

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria for Cervical Spondylosis of Neck Type: 1. All participants meet the 2018 expert consensus criteria for cervical spondylosis of neck type: (1) Patients report abnormal sensations such as pain in the occipital, neck, and shoulder regions, which may be accompanied by corresponding tender points. (2) Imaging results show degenerative changes in the cervical spine. (3) Exclude other cervical diseases or neck symptoms caused by other conditions. 2. Aged 18 years or older, voluntarily participating in this study, and signing the informed consent form. Inclusion Criteria for Nonspecific Low Back Pain: 1. Clinically diagnosed with chronic low back pain, characterized by intermittent or persistent pain between the 12th rib and the inferior gluteal fold, with or without radiation to the posterolateral thigh. 2. May have signs such as lumbar muscle tension, positive local tenderness, and limited lumbar range of motion, but normal muscle strength, muscle tone, sensation, and reflexes in both lower limbs, with a negative straight leg raise test. 3. Imaging examinations (X-ray, CT, MRI, etc.) show no significant positive findings. 4. Aged 18 years or older, voluntarily participating in this study, and signing the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria for cervical spondylosis of the neck type: 1. History of neck trauma or surgery; 2. Presence of congenital cervical spine deformities, spinal tuberculosis, bone tumors, or severe osteoporosis; 3. Pregnant women, individuals with mental disorders, or cognitive impairments who cannot cooperate with the experiment; 4. Unstable vital signs or other severe systemic diseases; 5. Received other physical therapy or treatments affecting efficacy assessment within the past 3 days. Exclusion criteria for non-specific low back pain: 1. Low back pain caused by a clear pathogenic reason (such as infection, trauma, injury, disease) or structural deformities (such as scoliosis); 2. History of severe spinal trauma or surgery; 3. Coexisting severe heart disease or visceral disease; 4. Pregnant women, individuals with mental disorders, or cognitive impairments who cannot cooperate with the experiment; 5. Received other physical therapy or treatments affecting efficacy assessment within the past 3 days.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale Score;

Secondary

MeasureTime frame
EuroQol Five -dimensional Questionnaire Score;

Countries

China

Contacts

Public ContactShan Jiang

China-Japan Friendship Hospital

landjiang@126.com+86 186 1033 5283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026